Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Infection Risks Associated with Infliximab and Adalimumab in Pediatric Inflammatory Bowel Disease Patients

  • By

  • Ning Lyu

  • Michaela Tracy

  • Sebastian Schneeweiss

  • Timothy J. Savage

  • July 10, 2026

Share

Original Source(s)

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease

  • by Ning Lyu, Michaela Tracy, Sebastian Schneeweiss, Timothy J. Savage

  • July 10, 2026

Related Content

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk

Malignancy as a rising contributor to mortality in patients with inflammatory bowel disease: a population-based epidemiological study

Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review